Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

First-in-human Safety Study of Hypoimmune Pancreatic Islet Transplantation in Adult Subjects With Type 1 Diabetes

NCT06239636 is registered in ClinicalTrials.gov with Per-Ola Carlsson as lead sponsor.

NCT NCT06239636
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06239636 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
First-in-human Safety Study of Hypoimmune Pancreatic Islet Transplantation in Adult Subjects With Type 1 Diabetes
Lead sponsor
Per-Ola Carlsson
Phase
Phase 1
Overall status
Recruiting
Start date
March 8, 2024
Completion date
June 30, 2025
Enrollment
2 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

type1diabetes